{"nct_id":"NCT04662710","title":"Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2020-12-30","start_date_type":"ACTUAL","primary_completion_date":"2024-10-29","primary_completion_date_type":"ACTUAL","completion_date":"2026-03-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}